ARQT - Arcutis Biotherapeutics, Inc.

📈 Is growth accelerating? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Revenue Growth YoY (%)	59.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+642%)	60.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+651%)	81.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+918%)	121.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1421%)	164.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1952%)	32.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+310%)	—	17.4% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+118%)	494.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+6082%)	1682.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+20930%)	—	5156.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+64355%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	N/M	55.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	69.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	37.5% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	—	54.8% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	63.8% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	75.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	—	61.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	11.5% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-3.1% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	—	-65.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-56.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	-12.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	10.6% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	54.9% Excellent ↑ Excellent Improving Year-over-year change in net income	54.9% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	29.2% Excellent → Excellent Stable Year-over-year change in net income	29.2% Excellent ↓ Excellent Declining Year-over-year change in net income	29.2% Excellent ↓ Excellent Declining Year-over-year change in net income	—	55.8% Excellent → Excellent Stable Year-over-year change in net income	55.8% Excellent ↑ Excellent Improving Year-over-year change in net income	55.8% Excellent ↑ Excellent Improving Year-over-year change in net income	—	-24.5% Weak → Weak Stable Year-over-year change in net income	-24.5% Weak ↑ Weak Improving Year-over-year change in net income	-24.5% Weak ↑ Weak Improving Year-over-year change in net income	—	-78.5% Weak → Weak Stable Year-over-year change in net income	-78.5% Weak ↓ Weak Declining Year-over-year change in net income	-78.5% Weak ↓ Weak Declining Year-over-year change in net income	—	-28.7% Weak → Weak Stable Year-over-year change in net income	-28.7% Weak ↑ Weak Improving Year-over-year change in net income	-28.7% Weak ↑ Weak Improving Year-over-year change in net income	—	-320.7% Weak → Weak Stable Year-over-year change in net income	-320.7% Weak Weak Year-over-year change in net income	-320.7% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	—	N/M	—	—	—	13.6% Fair Fair Year-over-year change in free cash flow	—	—	—	78.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-16.3% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	192.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	235.9% Excellent Excellent Compound annual revenue growth over 3 years	—	415.3% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Operating Margin (%) (%)	12.7% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-16%)	-8.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-157%)	14.2% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-5%)	8.6% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-43%)	-17.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-220%)	-37.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-348%)	-10.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-171%)	-87.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-682%)	-162.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1182%)	-63.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-525%)	—	-96.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-746%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-8.7% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-172%)	-10.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-189%)	13.4% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+12%)	-25.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-310%)	-30.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-356%)	-38.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-417%)	-15.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-226%)	-79.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-759%)	-114.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1056%)	-71.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-695%)	—	-210.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1852%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	9.6% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	2.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	20.2% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	-1.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	—	-47.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-1.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-63.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	-1.11x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.20x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.51x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.07x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.24x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.07x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	1.00x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	1.30x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	—	1.21x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.34x Good → Good Stable Free cash flow relative to reported net income Optimal: > 1x	1.61x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.24x Good Good Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Return on Invested Capital (%)	3.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-2.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	4.9% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	2.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	—	-11.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	—	-17.7% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-19.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	—	-12.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	—	-17.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	15.8% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	21.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	17.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	18.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	3.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-2.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	4.2% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	2.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-2.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-11.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-12.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-20.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-20.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-14.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-7.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-11.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—
Return on Common Equity (%) (%)	-5.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-134%)	-6.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-140%)	9.2% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-39%)	-15.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-206%)	-18.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-220%)	-17.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-217%)	-6.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-146%)	-22.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-251%)	-19.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-227%)	-15.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-205%)	—	-171.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1243%)	-99.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-763%)	-57.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-482%)	—	-23.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-258%)	-32.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-319%)	-25.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-269%)	—	-9.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-166%)	-8.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-158%)	-8.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-153%)	—	-16.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-208%)	-13.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-189%)	-11.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-177%)	19.3% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+29%)	12.6% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-16%)	17.2% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+15%)	21.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+45%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Debt to Equity (x)	0.49x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-18%)	0.58x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	0.58x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	0.69x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+14%)	0.78x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+30%)	0.75x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+26%)	0.68x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+13%)	1.31x Caution ↓ Caution Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+118%)	1.09x Caution ↓ Caution Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+82%)	0.90x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+50%)	2.28x Weak ↓ Weak Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+279%)	4.30x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+616%)	2.48x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+314%)	1.42x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+137%)	0.94x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+57%)	0.73x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+21%)	0.37x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-38%)	0.29x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-52%)	0.24x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-59%)	—	—	—	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	4.19x Fair ↑ Fair Improving Operating income divided by interest expense Optimal: > 5x	-3.13x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	7.24x Good ↑ Good Improving Operating income divided by interest expense Optimal: > 5x	3.25x Fair ↑ Fair Improving Operating income divided by interest expense Optimal: > 5x	—	-9.55x Weak Weak Operating income divided by interest expense Optimal: > 5x	-2.58x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-4.23x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-4.88x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-9.08x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.83x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-21.38x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-32.91x Weak Weak Operating income divided by interest expense Optimal: > 5x	-34.07x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$74.78M	$74.66M	$66.05M	$61.38M	$35.31M	$54.51M	$35.87M	$69.76M	$119.54M	$12.71M	$113.40M	$93.31M	$94.65M	$117.36M	$144.13M	$115.21M	$11.63M	$2.95M	$-24.10M	$-51.78M	$-89.13M	$-288.69M	$-65.08M	—	—	$-190.89M	—	—	—	—	—	—
Debt / EBITDA (x)	6.63x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-12.04x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	5.93x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	12.73x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-7.40x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-4.41x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-14.24x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-5.26x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-4.08x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-6.45x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-5.47x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-3.00x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.61x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-1.88x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.11x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.16x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Revenue per Share (USD)	$0.99	$814.73	—	$0.78	$0.64	$0.52	—	$0.36	$0.25	$0.45	—	$0.62	$0.08	$0.05	—	$0.01	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$0.11	$-0.09	$0.13	$0.06	$-0.13	$-0.20	$-0.08	$-0.33	$-0.42	$-0.32	—	$-0.73	$-1.16	$-1.31	—	$-1.89	$-1.31	$-1.27	—	$-1.14	$-0.84	—	—	$-1.01	$-0.94	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$0.10	$17.31	—	$-0.01	—	$-0.25	—	—	—	$-0.28	—	—	—	$-1.31	—	—	—	$-1.13	—	—	—	—	—	$-0.90	$-0.69	—	—	—	—	—	—	—
Book Value per Share (USD)	$1.76	$1.52	$1.54	$1.31	$1.16	$1.20	$1.34	$1.34	$1.60	$1.95	$0.92	$0.76	$1.31	$2.28	$3.43	$4.45	$3.79	$4.94	$5.92	$7.24	$8.28	$9.04	$6.24	$4.58	$5.56	$6.46	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$1.65	$1.40	$1.42	$1.19	$1.03	$1.06	$1.26	$1.26	$1.55	$1.89	$0.85	$0.65	$1.20	$2.16	$3.32	$4.32	$3.79	$4.94	$5.92	$7.24	$8.28	$9.04	$6.24	$4.58	$5.56	$6.46	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	130.52M	129,365	—	127.62M	127.00M	126.04M	—	124.30M	123.48M	111.05M	—	61.73M	61.43M	61.17M	—	57.09M	51.42M	50.51M	—	50.10M	50.00M	—	—	37.75M	37.59M	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Working Capital (USD)	$307.33M	$274.85M	$281.39M	$249.45M	$228.84M	$232.54M	$254.81M	$251.29M	$383.24M	$420.75M	$283.76M	$239.66M	$272.21M	$330.65M	$399.60M	$459.62M	$267.94M	$325.95M	$369.45M	$362.71M	$414.21M	$450.66M	$270.22M	—	—	$241.66M	—	—	—	—	—	—
LT Debt (USD)	$108.90M	$109.42M	$108.96M	$108.50M	$108.05M	$107.62M	$107.20M	$204.61M	$203.81M	$202.80M	$201.80M	$200.78M	$199.77M	$198.76M	$197.77M	$196.75M	$73.14M	$72.74M	$72.35M	—	—	—	$0.00	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$220.58M	$189.65M	$189.48M	$158.07M	$138.97M	$142.66M	$157.54M	$156.64M	$186.43M	$224.94M	$88.67M	$46.72M	$80.51M	$139.73M	$209.58M	$270.77M	$195.38M	$253.77M	$297.68M	$363.00M	$414.49M	$450.99M	$270.62M	$173.07M	$208.92M	$241.88M	$-65.03M	$-52.95M	$-38.66M	$-30.54M	$-23.99M	$-4.99M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Sales/Revenue/Turnover (USD)	$129.86M	$105.40M	$129.50M	$99.22M	$81.50M	$65.85M	$71.36M	$44.76M	$30.86M	$49.57M	—	$38.11M	$5.19M	$2.78M	—	$725.00K	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	—	—	—	—	—	$153.00K	$105.00K	$161.00K	$164.00K	$170.00K	—	$200.00K	$198.00K	$175.00K	—	$157.00K	$155.00K	$150.00K	—	$116.00K	$104.00K	$98.00K	—	$30.00K	$30.00K	$27.00K	$24.00K	$19.00K	$20.00K	$5.00K	—	—
Net Income, GAAP (USD)	$-11.29M	$-11.29M	$17.39M	$-25.06M	$-25.06M	$-25.06M	$-10.79M	$-35.38M	$-35.38M	$-35.38M	—	$-80.10M	$-80.10M	$-80.10M	—	$-64.32M	$-64.32M	$-64.32M	—	$-36.04M	$-36.04M	$-36.04M	—	$-28.01M	$-28.01M	$-28.01M	$-12.57M	$-6.66M	$-6.66M	$-6.66M	—	—
Operating Cash Flow (USD)	$12.64M	$2.24M	$26.18M	$-1.75M	—	$-30.38M	$-748.00K	—	—	$-31.60M	—	—	—	$-80.34M	—	—	—	$-56.98M	—	—	—	$-46.20M	—	$-33.69M	$-25.76M	$-21.01M	$-16.80M	$-10.72M	$-8.24M	$-7.07M	—	—

Arcutis Biotherapeutics, Inc.

Analytical Summary

32-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ARQT with peers